A. Talu

发表

High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment

J. Parry, T. Rhodes, A. Uusküla, 2006, AIDS.

Association Between HIV-1 Tropism and CCR5 Human Haplotype E in a Caucasian Population

A. Uusküla, K. Rüütel, R. Avi, 2014, Journal of acquired immune deficiency syndromes.

Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia

T. Rhodes, A. Uusküla, M. Rahu, 2009, AIDS care.

Evaluating Recruitment among Female Sex Workers and Injecting Drug Users at Risk for HIV Using Respondent-driven Sampling in Estonia

L. Johnston, D. D. Jarlais, M. Raag, 2010, Journal of Urban Health.

Estimating injection drug use prevalence using state wide administrative data sources: Estonia, 2004

A. Uusküla, K. Rüütel, G. Hay, 2007 .

HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic

D. D. Des Jarlais, M. Raag, A. Uusküla, 2017, PloS one.

Frequency and factors associated with providing injection initiation assistance in Tallinn, Estonia.

D. D. Des Jarlais, S. Tross, M. Raag, 2018, Drug and alcohol dependence.

High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs.

M. Kals, D. D. Des Jarlais, T. Rhodes, 2008, Journal of public health.

Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia

D. D. Des Jarlais, A. Uusküla, K. Rüütel, 2009, Harm reduction journal.

REPORT TO THE EMCDDA by the Reitox National Focal Point ESTONIA DRUG SITUATION 2003

A. Talu, Katri Abel, A. Neuman, 2003 .

A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs

A. Uusküla, E. Kallas, K. Rüütel, 2016, PloS one.

CCR5 Haplotypes Influence HCV Serostatus in Caucasian Intravenous Drug Users

A. Uusküla, K. Rüütel, R. Avi, 2013, PloS one.

CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users.

A. Uusküla, K. Rüütel, R. Avi, 2010, The Journal of infectious diseases.

CCL 3 L 1 Copy Number Is a Strong Genetic Determinant of HIV Seropositivity in Caucasian Intravenous Drug Users

A. Uusküla, K. Rüütel, R. Avi, 2010 .

Emergent properties of HIV risk among injection drug users in Tallinn, Estonia: synthesis of individual and neighbourhood-level factors

R. Ahas, Siiri Silm, D. D. Des Jarlais, 2010, Sexually Transmitted Infections.

Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: evidence from cross-sectional surveys.

D. D. Des Jarlais, A. Uusküla, K. Rüütel, 2013, The International journal on drug policy.

Implementing an Updated “Break the Cycle” Intervention to Reduce Initiating Persons into Injecting Drug Use in an Eastern European and a US “opioid epidemic” Setting

D. D. Des Jarlais, S. Tross, M. Raag, 2019, AIDS and Behavior.

Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia

A. Uusküla, D. M. Barnes, A. Talu, 2021, Harm Reduction Journal.

Adapted “Break the Cycle for Avant Garde” intervention to reduce injection assisting and promoting behaviours in people who inject drugs in Tallinn, Estonia: A pre- post trial

D. D. Des Jarlais, S. Tross, M. Raag, 2022, medRxiv.

A Multistage Process Model of How a Person Who Currently Injects Drugs Comes to Assist Persons Who Do not Inject with Their First Injections

D. D. Des Jarlais, S. Tross, M. Raag, 2021, Frontiers in Sociology.

A decline in the prevalence of injecting drug users in Estonia, 2005-2009.

D. D. Des Jarlais, A. Uusküla, A. Talu, 2013, The International journal on drug policy.

Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia

M. Kals, D. D. Des Jarlais, A. Uusküla, 2011, BMC public health.

Mortality of registered drug users in Central Asia.

V. Mravčík, A. Talu, T. Zábranský, 2014, The International journal on drug policy.

HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.

T. Rhodes, A. Uusküla, M. Rahu, 2010, The International journal on drug policy.

Should Pharmacists have a Role in Harm Reduction Services for IDUs? A Qualitative Study in Tallinn, Estonia

A. Uusküla, S. Vorobjov, A. Talu, 2009, Journal of Urban Health.

The fentanyl epidemic in Estonia: factors in its evolution and opportunities for a comprehensive public health response, a scoping review.

A. Uusküla, A. Talu, L. Lemsalu, 2020, The International journal on drug policy.

Multiple routes of drug administration and HIV risk among injecting drug users.

D. D. Des Jarlais, A. Uusküla, K. Rüütel, 2012, Journal of substance abuse treatment.

Regular article Multiple routes of drug administration and HIV risk among injecting drug users

K. Rüütel, S. Vorobjov, A. Talu, 2012 .

Post-Soviet Central Asia: a summary of the drug situation.

V. Mravčík, A. Talu, T. Zábranský, 2014, The International journal on drug policy.

Risk for Heterosexual HIV Transmission Among Non-Injecting Female Partners of Injection Drug Users in Estonia

M. Kals, J. M. McMahon, A. Uusküla, 2013, AIDS and Behavior.

Prevalence of IGRA-positivity and risk factors for tuberculosis among injecting drug users in Estonia and Latvia.

K. Kliiman, A. Uusküla, K. Rüütel, 2014, The International journal on drug policy.

Children and Adolescents Involved in Drug Use and Trafficking: A Rapid Assessment

A. Talu, A. Kurbatova, N. Kalikova, 2002 .

Institute of Experimental and Clinical Medicine Estonian Drug Monitoring Centre Estonian National Focal Point ESTONIA DRUG SITUATION 2002

A. Talu, Katri Abel, G. Denissov, 2003 .